Observational studyJournal of managed care & specialty pharmacy2023

Evaluation of disease-free survival as a predictor of overall survival and assessment of real-world burden of disease recurrence in resected early-stage non-small cell lung cancer.

Howard West et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.